Pages with the fewest revisions

From The School of Biomedical Sciences Wiki
Jump to: navigation, search

Showing below up to 500 results starting with #501.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Genomic library ‎(2 revisions)
  2. Stromatolites ‎(2 revisions)
  3. Chemiosmotic hypothesis ‎(2 revisions)
  4. Presynaptic modulation ‎(2 revisions)
  5. Ampere ‎(2 revisions)
  6. FADH2 ‎(2 revisions)
  7. Dimers ‎(2 revisions)
  8. Inosine ‎(2 revisions)
  9. 'sticky' ends ‎(2 revisions)
  10. Complementation group ‎(2 revisions)
  11. Zellweger Syndrome ‎(2 revisions)
  12. Isoform ‎(2 revisions)
  13. Plant cells ‎(2 revisions)
  14. Transition state ‎(2 revisions)
  15. Celiac disease ‎(2 revisions)
  16. Molecular formula ‎(2 revisions)
  17. Postsynaptic membrane ‎(2 revisions)
  18. Oxidised ‎(2 revisions)
  19. Deoxygenated blood ‎(2 revisions)
  20. Synteny ‎(2 revisions)
  21. Chromosome walking ‎(2 revisions)
  22. Citrate carries acetyl groups ‎(2 revisions)
  23. Fats ‎(2 revisions)
  24. Disease gene ‎(2 revisions)
  25. Cofactor ‎(2 revisions)
  26. Fluorine ‎(2 revisions)
  27. Pulmonary vein ‎(2 revisions)
  28. 3q22.1 ‎(2 revisions)
  29. Hepatitis B ‎(2 revisions)
  30. Electromagnetic spectrum ‎(2 revisions)
  31. Phosphorylase ‎(2 revisions)
  32. Coupled Pumps ‎(2 revisions)
  33. Gamma rays ‎(2 revisions)
  34. Endoderm ‎(2 revisions)
  35. Plasmodium falciparum ‎(2 revisions)
  36. Transposable elements ‎(2 revisions)
  37. DNA Taq polymerase ‎(2 revisions)
  38. Orthophosphate ‎(2 revisions)
  39. Progesterone only pill ‎(2 revisions)
  40. Deuterium ‎(2 revisions)
  41. T-helper cell ‎(2 revisions)
  42. Diet ‎(2 revisions)
  43. Closed complex ‎(2 revisions)
  44. Nerve tissue ‎(2 revisions)
  45. Saturated hydrocarbon ‎(2 revisions)
  46. Mannose ‎(2 revisions)
  47. Tertiary structure ‎(2 revisions)
  48. Nitric Oxide ‎(2 revisions)
  49. Phosphlipid ‎(2 revisions)
  50. Heterocyclic ‎(2 revisions)
  51. Crick ‎(2 revisions)
  52. Trimeric G-proteins ‎(2 revisions)
  53. Humulin ‎(2 revisions)
  54. Morphine ‎(2 revisions)
  55. Hydroxyl groups ‎(2 revisions)
  56. Strong nuclear force ‎(2 revisions)
  57. Chemistry ‎(2 revisions)
  58. Uric acid ‎(2 revisions)
  59. PMAT ‎(2 revisions)
  60. Symptom ‎(2 revisions)
  61. Vimentin ‎(2 revisions)
  62. Prostacyclin ‎(2 revisions)
  63. Vitamins ‎(2 revisions)
  64. Anabolic ‎(2 revisions)
  65. Inositiol 1,4,5 triphosphate ‎(2 revisions)
  66. HINDIII ‎(2 revisions)
  67. Neuromuscular junctions ‎(2 revisions)
  68. C-terminus ‎(2 revisions)
  69. Megakaryocytes ‎(2 revisions)
  70. Intrinsic Pathway ‎(2 revisions)
  71. Complementation test ‎(2 revisions)
  72. Sex linkage ‎(2 revisions)
  73. Fugu Rubripes ‎(2 revisions)
  74. Metabolic processes ‎(2 revisions)
  75. Quiescence ‎(2 revisions)
  76. Isolating DNA ‎(2 revisions)
  77. G protein (Gs) ‎(2 revisions)
  78. Randomised controlled trials ‎(2 revisions)
  79. Acidity ‎(2 revisions)
  80. Reduction ‎(2 revisions)
  81. Trisomys ‎(2 revisions)
  82. DGTP ‎(2 revisions)
  83. Retinitis pigmentosa ‎(2 revisions)
  84. Equational Division ‎(2 revisions)
  85. Linear relationship ‎(2 revisions)
  86. Postsynaptic neurone ‎(2 revisions)
  87. Alkane ‎(2 revisions)
  88. Hypoglycaemia ‎(2 revisions)
  89. Oxidising agent ‎(2 revisions)
  90. Chimerism ‎(2 revisions)
  91. Amine ‎(2 revisions)
  92. Deoxynucleoside triphosphate ‎(2 revisions)
  93. Natural killer cells ‎(2 revisions)
  94. Citric Acid Cycle ‎(2 revisions)
  95. Gregory Mendel ‎(2 revisions)
  96. Protein coding genes ‎(2 revisions)
  97. Androgen ‎(2 revisions)
  98. Insulin receptor substrate ‎(2 revisions)
  99. Selenocysteine ‎(2 revisions)
  100. X-ray diffraction ‎(2 revisions)
  101. DsRNA ‎(2 revisions)
  102. Phosphatases ‎(2 revisions)
  103. Tracheotomy ‎(2 revisions)
  104. Histamine receptors ‎(2 revisions)
  105. Recepter Tyrosine Kinases ‎(2 revisions)
  106. Endogenous ‎(2 revisions)
  107. Active immunity ‎(2 revisions)
  108. Charges ‎(2 revisions)
  109. Muscle Twitch ‎(2 revisions)
  110. Lipoprotein ‎(2 revisions)
  111. IGF (Insulin Growth Factor) ‎(2 revisions)
  112. Cholecystokinin ‎(2 revisions)
  113. Biochemistry ‎(2 revisions)
  114. Aminoacyl ‎(2 revisions)
  115. Incomplete dominance ‎(2 revisions)
  116. Parathyroid gland ‎(2 revisions)
  117. Weismann's experiment ‎(3 revisions)
  118. Interpro ‎(3 revisions)
  119. Test crosses ‎(3 revisions)
  120. Competitive antagonist ‎(3 revisions)
  121. Menstrual cycle ‎(3 revisions)
  122. Islet Amyloidosis ‎(3 revisions)
  123. Phosphocreatine ‎(3 revisions)
  124. Normal flora ‎(3 revisions)
  125. Null mutation ‎(3 revisions)
  126. Autoimmune disorder ‎(3 revisions)
  127. Triple bond ‎(3 revisions)
  128. Ribonucleoproteins ‎(3 revisions)
  129. Base pairing ‎(3 revisions)
  130. Chromosomal inversion ‎(3 revisions)
  131. Viral meningitis ‎(3 revisions)
  132. Prostaglandin ‎(3 revisions)
  133. The Holliday Model of DNA cossover ‎(3 revisions)
  134. Zinc finger ‎(3 revisions)
  135. Edwards syndrome ‎(3 revisions)
  136. Core histones ‎(3 revisions)
  137. Plants ‎(3 revisions)
  138. Acidosis ‎(3 revisions)
  139. Le chateliers principle ‎(3 revisions)
  140. Tritium ‎(3 revisions)
  141. Organic chemistry ‎(3 revisions)
  142. Bacterial cells ‎(3 revisions)
  143. UV-Vis Spectrophotometry ‎(3 revisions)
  144. Griffith experiment ‎(3 revisions)
  145. Bone marrow ‎(3 revisions)
  146. Major histocompatibility complex ‎(3 revisions)
  147. Watson-Crick ‎(3 revisions)
  148. Thermostable ‎(3 revisions)
  149. G0 phase ‎(3 revisions)
  150. RNA primer ‎(3 revisions)
  151. Transamination ‎(3 revisions)
  152. Sodium chloride ‎(3 revisions)
  153. Polynucleotide Chain ‎(3 revisions)
  154. Lipoproteins ‎(3 revisions)
  155. Allery to Eggs ‎(3 revisions)
  156. Vena cavae ‎(3 revisions)
  157. Initiation factor ‎(3 revisions)
  158. Bromodomains ‎(3 revisions)
  159. Mass spectrometry ‎(3 revisions)
  160. Nitric oxide ‎(3 revisions)
  161. Frameshift mutation ‎(3 revisions)
  162. Menstruation ‎(3 revisions)
  163. Normality ‎(3 revisions)
  164. Carboxylic acid group ‎(3 revisions)
  165. Kernicterus ‎(3 revisions)
  166. Huntington's disease ‎(3 revisions)
  167. Ligand-gated sodium channels ‎(3 revisions)
  168. Eukarya ‎(3 revisions)
  169. Alpha carbon ‎(3 revisions)
  170. NMDA receptor ‎(3 revisions)
  171. Diplococci ‎(3 revisions)
  172. Fischer projection ‎(3 revisions)
  173. Proton gradient ‎(3 revisions)
  174. Cell Lysis ‎(3 revisions)
  175. Regulator gene ‎(3 revisions)
  176. Hydrogen bond ‎(3 revisions)
  177. Global warming ‎(3 revisions)
  178. Sugar ‎(3 revisions)
  179. Beta Barrel ‎(3 revisions)
  180. Nephrogenic diabetes insipidus ‎(3 revisions)
  181. Protein domain ‎(3 revisions)
  182. Half life ‎(3 revisions)
  183. RNA synthesis ‎(3 revisions)
  184. Gap junctions ‎(3 revisions)
  185. Receptor-mediated endocytosis ‎(3 revisions)
  186. B-cells ‎(3 revisions)
  187. Epidermis ‎(3 revisions)
  188. Estrogen receptor ‎(3 revisions)
  189. Diagnosis ‎(3 revisions)
  190. Amphiphatic ‎(3 revisions)
  191. Digestion ‎(3 revisions)
  192. Schizophrenia ‎(3 revisions)
  193. Interstitial fluids ‎(3 revisions)
  194. Heart Attack ‎(3 revisions)
  195. Antisense DNA ‎(3 revisions)
  196. Thymus ‎(3 revisions)
  197. Ketamine ‎(3 revisions)
  198. Ligand gated ion channels ‎(3 revisions)
  199. DNA repair ‎(3 revisions)
  200. Hyperpolarisation ‎(3 revisions)
  201. Eukaryota ‎(3 revisions)
  202. Long terminal receptor ‎(3 revisions)
  203. Deletion mutation ‎(3 revisions)
  204. Ileum ‎(3 revisions)
  205. PTBI ‎(3 revisions)
  206. Factor independent termination ‎(3 revisions)
  207. Inositol 1,4,5-trisphosphate ‎(3 revisions)
  208. H index ‎(3 revisions)
  209. Anti parallel strands ‎(3 revisions)
  210. Nuclear receptors ‎(3 revisions)
  211. Reiji Okazaki ‎(3 revisions)
  212. Enzyme-Substrate Complex ‎(3 revisions)
  213. Leaves ‎(3 revisions)
  214. Polygenic disease ‎(3 revisions)
  215. Organic molecules ‎(3 revisions)
  216. Retinoblastoma protein ‎(3 revisions)
  217. Bacterial chromosomes ‎(3 revisions)
  218. Potassium ions ‎(3 revisions)
  219. Hypomagnesaemia ‎(3 revisions)
  220. Chiral centre ‎(3 revisions)
  221. Growth Hormone ‎(3 revisions)
  222. Fatty acids ‎(3 revisions)
  223. Protein folding ‎(3 revisions)
  224. Integral membrane proteins ‎(3 revisions)
  225. Follicle-stimulating Hormone ‎(3 revisions)
  226. Photo 51 ‎(3 revisions)
  227. Abdomen ‎(3 revisions)
  228. Cell signalling molecules ‎(3 revisions)
  229. Genetic variation ‎(3 revisions)
  230. Osmoreceptors ‎(3 revisions)
  231. Unit of Enzyme ‎(3 revisions)
  232. Svedberg unit ‎(3 revisions)
  233. Glycosaminoglycan ‎(3 revisions)
  234. Guanosine diphosphate ‎(3 revisions)
  235. Neuraminidase ‎(3 revisions)
  236. Serotype ‎(3 revisions)
  237. Nuclear dimorphism ‎(3 revisions)
  238. Molality ‎(3 revisions)
  239. Reciprocal translocation ‎(3 revisions)
  240. Lamellipodia ‎(3 revisions)
  241. Centrioles ‎(3 revisions)
  242. Ligands ‎(3 revisions)
  243. Longterm potentiation ‎(3 revisions)
  244. Urine ‎(3 revisions)
  245. Golgi apparatus ‎(3 revisions)
  246. Sacromere ‎(3 revisions)
  247. Facultative heterochromatin ‎(3 revisions)
  248. Protazoa ‎(3 revisions)
  249. Metabolome ‎(3 revisions)
  250. Zwitterion ‎(3 revisions)
  251. Coronary artery ‎(3 revisions)
  252. Nuclear spallation ‎(3 revisions)
  253. Carrier protein ‎(3 revisions)
  254. Plasma cell ‎(3 revisions)
  255. TATA promoter ‎(3 revisions)
  256. Periplasmic space ‎(3 revisions)
  257. Antigen receptor ‎(3 revisions)
  258. Phosphate groups ‎(3 revisions)
  259. Abnormal Processing ‎(3 revisions)
  260. LacY gene ‎(3 revisions)
  261. Pluripotent embryonic stem cells ‎(3 revisions)
  262. Tricarboxylic Acid ‎(3 revisions)
  263. Oncology ‎(3 revisions)
  264. DNA ladder ‎(3 revisions)
  265. Chemical bonds ‎(3 revisions)
  266. Muscle hypertrophy ‎(3 revisions)
  267. Rho independent terminators ‎(3 revisions)
  268. IP3 receptor ‎(3 revisions)
  269. Glycosdic bond ‎(3 revisions)
  270. Visible light ‎(3 revisions)
  271. Co-dominant ‎(3 revisions)
  272. Neuroanatomy ‎(3 revisions)
  273. Anode ‎(3 revisions)
  274. Merozoites ‎(3 revisions)
  275. Isocitrate dehydrogenase ‎(3 revisions)
  276. Heterotroph ‎(3 revisions)
  277. Nuclear division ‎(3 revisions)
  278. Radioactive ‎(3 revisions)
  279. Cation ‎(3 revisions)
  280. Molar ‎(3 revisions)
  281. Laminin ‎(3 revisions)
  282. Oxidation number ‎(3 revisions)
  283. Imatinib ‎(3 revisions)
  284. Codons ‎(3 revisions)
  285. Hemi-desmosomes ‎(3 revisions)
  286. Metagenomics ‎(3 revisions)
  287. Arachidonic acid ‎(3 revisions)
  288. Phospholipids ‎(3 revisions)
  289. Midbrain ‎(3 revisions)
  290. Auxins ‎(3 revisions)
  291. Amino acid ‎(3 revisions)
  292. Clatharin ‎(3 revisions)
  293. Nernst equation ‎(3 revisions)
  294. Nicotinamide ‎(3 revisions)
  295. C value paradox ‎(3 revisions)
  296. Formative Assessment ‎(3 revisions)
  297. Antigenic drift ‎(3 revisions)
  298. Ions ‎(3 revisions)
  299. Phosphates ‎(3 revisions)
  300. Transcription Factor H ‎(3 revisions)
  301. Atrophy ‎(3 revisions)
  302. LacZα gene ‎(3 revisions)
  303. Genome ‎(3 revisions)
  304. Glucose 6-phosphate ‎(3 revisions)
  305. Liver X receptor ‎(3 revisions)
  306. Sweat Gland ‎(3 revisions)
  307. NADP ‎(3 revisions)
  308. Amnesia ‎(3 revisions)
  309. Schwann cell ‎(3 revisions)
  310. Nitrogen narcosis ‎(3 revisions)
  311. Serum ‎(3 revisions)
  312. ADP-ribosylation ‎(3 revisions)
  313. Cardiac Arrythmia ‎(3 revisions)
  314. Acetylation ‎(3 revisions)
  315. Crystal violet ‎(3 revisions)
  316. Obestiy ‎(3 revisions)
  317. Recombinant DNA technology ‎(3 revisions)
  318. Autophosphorylate ‎(3 revisions)
  319. Start codon ‎(3 revisions)
  320. Motor protein ‎(3 revisions)
  321. Bacillus Calmette-Guérin (BCG) ‎(3 revisions)
  322. Myelin sheath ‎(3 revisions)
  323. Riboswitches ‎(3 revisions)
  324. Bohr effect ‎(3 revisions)
  325. Analgesic ‎(3 revisions)
  326. Flow cytometry ‎(3 revisions)
  327. Melanin ‎(3 revisions)
  328. 2-methylpropane ‎(3 revisions)
  329. Isopeptide bond ‎(3 revisions)
  330. Tongue ‎(3 revisions)
  331. Mimivirus ‎(3 revisions)
  332. Cyctic fibrosis ‎(3 revisions)
  333. Sphingomyelin ‎(3 revisions)
  334. Troponin T ‎(3 revisions)
  335. DNA Polymerase 1 ‎(3 revisions)
  336. Hydrogen ions ‎(3 revisions)
  337. Organs ‎(3 revisions)
  338. Chaperone-mediated autophagy ‎(3 revisions)
  339. Lipid droplets ‎(3 revisions)
  340. Chloride ‎(3 revisions)
  341. Granulocytes ‎(3 revisions)
  342. TFIIB ‎(3 revisions)
  343. Nerve cell ‎(3 revisions)
  344. Angiotensin I ‎(3 revisions)
  345. Hashimoto's thyroiditis ‎(3 revisions)
  346. Pyrimidines ‎(3 revisions)
  347. Noncovalent bonds ‎(3 revisions)
  348. Histone Methylation ‎(3 revisions)
  349. Catabolism of amino acids ‎(3 revisions)
  350. Trigeminal nerve ‎(3 revisions)
  351. Cytokines ‎(3 revisions)
  352. Respiratory system ‎(3 revisions)
  353. Polyphenol ‎(3 revisions)
  354. DNA ligase I ‎(3 revisions)
  355. Chemical energy ‎(3 revisions)
  356. Ethene ‎(3 revisions)
  357. Allosteric site ‎(3 revisions)
  358. DdNTP ‎(3 revisions)
  359. NADP+ ‎(3 revisions)
  360. Prophase I ‎(3 revisions)
  361. Amyloid ‎(3 revisions)
  362. T lymphocytes ‎(3 revisions)
  363. CoA ‎(3 revisions)
  364. HCAs ‎(3 revisions)
  365. Mesophyll cell ‎(3 revisions)
  366. Thyroid stimulating hormone ‎(3 revisions)
  367. Heterozygotes ‎(3 revisions)
  368. Nuclear fission ‎(3 revisions)
  369. GPCR ‎(3 revisions)
  370. Transition State ‎(3 revisions)
  371. Poly-A tail ‎(3 revisions)
  372. Trisomy 18 ‎(3 revisions)
  373. D-glucose ‎(3 revisions)
  374. Hypertonic solution ‎(3 revisions)
  375. Glyceraldehyde ‎(3 revisions)
  376. Chromosome 4 ‎(3 revisions)
  377. Naproxen ‎(3 revisions)
  378. Blood stream ‎(3 revisions)
  379. Negative charge ‎(3 revisions)
  380. Fas signalling ‎(3 revisions)
  381. Insertional inactivation ‎(3 revisions)
  382. Secretory vesicle ‎(3 revisions)
  383. Fluid mosaic model ‎(3 revisions)
  384. RNA interference ‎(3 revisions)
  385. Electrochemical gradient ‎(3 revisions)
  386. Oligomer ‎(3 revisions)
  387. Sphingosine ‎(3 revisions)
  388. Allele ‎(3 revisions)
  389. Lymph ‎(3 revisions)
  390. Impetigo ‎(3 revisions)
  391. Parasite ‎(3 revisions)
  392. Females ‎(3 revisions)
  393. Ipatropium ‎(3 revisions)
  394. Carboxyl ‎(3 revisions)
  395. Mitotic spindle ‎(3 revisions)
  396. Adaptive immune system ‎(3 revisions)
  397. Human genome ‎(3 revisions)
  398. Glucose transporter ‎(3 revisions)
  399. Deacetylation ‎(3 revisions)
  400. Idiopathic ‎(3 revisions)
  401. Sympathetic nervous system ‎(3 revisions)
  402. F-plasmid ‎(3 revisions)
  403. MAP kinase kinase ‎(3 revisions)
  404. Wildtype ‎(3 revisions)
  405. Phosphoglycerides ‎(3 revisions)
  406. Nuclear lamina ‎(3 revisions)
  407. Cardiac cycle ‎(3 revisions)
  408. GRB2 ‎(3 revisions)
  409. Homo erectus ‎(3 revisions)
  410. Hydrocarbons ‎(3 revisions)
  411. Glyceraldehyde-3-phosphate ‎(3 revisions)
  412. Paneth cell ‎(3 revisions)
  413. Narcolepsy ‎(3 revisions)
  414. Neutrino ‎(3 revisions)
  415. The central dogma ‎(3 revisions)
  416. Gametocytes ‎(3 revisions)
  417. Enzyme active site ‎(3 revisions)
  418. Legionella pneumophila ‎(3 revisions)
  419. Polymerisation ‎(3 revisions)
  420. Hydrolases ‎(3 revisions)
  421. Rosalind Franklin ‎(3 revisions)
  422. Bile ‎(3 revisions)
  423. Importins ‎(3 revisions)
  424. Dideoxynucleotide ‎(3 revisions)
  425. TFIIE ‎(3 revisions)
  426. Hayflick Limit ‎(3 revisions)
  427. Ca2+ signalling toolkit ‎(3 revisions)
  428. Thrombin ‎(3 revisions)
  429. Hess's Law ‎(3 revisions)
  430. Karyogram ‎(3 revisions)
  431. Transducin(Gt) ‎(3 revisions)
  432. Accession number ‎(3 revisions)
  433. Histone deacetylases ‎(3 revisions)
  434. Endosomes ‎(3 revisions)
  435. Point mutation ‎(3 revisions)
  436. Oogenesis ‎(3 revisions)
  437. Alcohol group ‎(3 revisions)
  438. Glucuronidation ‎(3 revisions)
  439. Glycosyltransferase ‎(3 revisions)
  440. Medulla ‎(3 revisions)
  441. Fructose-1,6-bisphosphate ‎(3 revisions)
  442. AMP ‎(3 revisions)
  443. Coomassie blue ‎(3 revisions)
  444. Heterozygous advantage ‎(3 revisions)
  445. Ran-GAP ‎(3 revisions)
  446. Transition mutation ‎(3 revisions)
  447. Acetyltransferase ‎(3 revisions)
  448. Homo sapiens ‎(3 revisions)
  449. Organ of corti ‎(3 revisions)
  450. Mucus ‎(3 revisions)
  451. Postsynaptic cell ‎(3 revisions)
  452. Vacuole ‎(3 revisions)
  453. Amide bond ‎(3 revisions)
  454. Syncytium ‎(3 revisions)
  455. Bombay Phenotype ‎(3 revisions)
  456. Coenzyme Q ‎(3 revisions)
  457. Melanoma ‎(3 revisions)
  458. Heparin ‎(3 revisions)
  459. Arcoxia ‎(3 revisions)
  460. Hippocampus ‎(3 revisions)
  461. Cell lysis ‎(3 revisions)
  462. Polymers ‎(3 revisions)
  463. DNA Structure ‎(3 revisions)
  464. Muscarinic acetylcholine receptor ‎(3 revisions)
  465. Dalton ‎(3 revisions)
  466. Chloroplast ‎(3 revisions)
  467. Progesterone ‎(3 revisions)
  468. Clonal selection ‎(3 revisions)
  469. Anhydrides ‎(3 revisions)
  470. Electrophoretic mobility shift assay ‎(3 revisions)
  471. Histone variants ‎(3 revisions)
  472. Endosymbiont theory ‎(3 revisions)
  473. Humans ‎(3 revisions)
  474. Ribonucleic acid ‎(3 revisions)
  475. Logarithm ‎(3 revisions)
  476. Urethra ‎(3 revisions)
  477. Alpha-carbon ‎(3 revisions)
  478. Decarboxylation ‎(3 revisions)
  479. Glycosyltransferases ‎(3 revisions)
  480. Villi ‎(3 revisions)
  481. Blood vessel ‎(3 revisions)
  482. Vitamin K ‎(3 revisions)
  483. HDL ‎(3 revisions)
  484. Second Law of Thermodynamics ‎(3 revisions)
  485. Wilson's disease ‎(3 revisions)
  486. Anti-parallel ‎(3 revisions)
  487. Metabolic pathway ‎(3 revisions)
  488. Quaternary structures ‎(3 revisions)
  489. Aptamer ‎(3 revisions)
  490. Edward's syndrome ‎(3 revisions)
  491. Hexokinase ‎(3 revisions)
  492. Microtuble ‎(3 revisions)
  493. Ran GTPase ‎(3 revisions)
  494. Aster ‎(3 revisions)
  495. Empirical formula ‎(3 revisions)
  496. Cuvette ‎(3 revisions)
  497. Le Chatelier's Principle ‎(3 revisions)
  498. Organelle ‎(3 revisions)
  499. Glial cell ‎(3 revisions)
  500. COP II ‎(3 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Personal tools
Namespaces
Variants
Views
Actions
Navigation
Toolbox